Juvena Therapeutics - Meet the DM Drug Developers 2024

Presented on July 19, 2024.

Juvena Therapeutics presents on their myotonic dystrophy program, focusing on JUV-161, a therapeutic protein that has demonstrated the ability to restore muscle differentiation, promote survival, increase strength, and improve metabolism by restoring protein signaling mechanisms that are crucial for muscular and metabolic homeostasis.

Learn more about Juvena Therapeutics at https://www.juvenatherapeutics.com/

==========================

Presenters include:
- Hanadie Yousef, PhD, Chief Executive Officer & Co-Founder, Juvena Therapeutics

- Jeremy O'Connell, PhD, Chief Scientific Officer & Co-Founder, Juvena Therapeutics

- Bernard (Barney) King, MD, MBA, Chief Medical Officer, Juvena Therapeutics

- John Day, MD, PhD, Scientific & Clinical Advisor, Juvena Therapeutics; and Professor of Neurology, Pediatrics (Genetics) and Pathology, Director of the Division of Neuromuscular Medicine at Stanford University

==========================

Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions.

Find all our upcoming Meet the DM Drug Developers dates at https://www.myotonic.org/meet-dm-drug...

Learn more about myotonic dystrophy at https://www.myotonic.org/

==========================

MDF Resources referenced in this video:

Toolkits & Publications - https://www.myotonic.org/toolkits-pub...

Support Groups - https://www.myotonic.org/find-support

Digital Academy - https://www.myotonic.org/digital-academy

Calendar of Events - https://www.myotonic.org/calendar/month

DM Drug Development Pipeline - https://www.myotonic.org/pipeline

Myotonic Dystrophy Family Registry - https://myotonicregistry.patientcross...

2025 MDF Annual Conference - https://www.myotonic.org/2025-mdf-ann...

Sign up for My Dispatch, our monthly e-newsletter - https://www.myotonic.org/sign-emails-0

==========================

0:00:00 Welcome & Introduction
0:09:13 Overview of JUV-161, a Muscle Regenerating Fusion Protein
0:35:45 Questions & Answers
1:03:50 Closing Remarks